pharmacie et médicaments – Conséquences préoccupantes du projet de réduction du plafond des remises

This written question addresses the potential negative impacts of proposed cuts to rebates for pharmaceutical companies. It seeks clarification on the consequences for the availability and pricing of medicines. The question highlights concerns for patients, healthcare providers, and the pharmaceutical industry. It aims to understand how these changes might affect access to essential treatments and the sector's stability.